On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc, about clinical trial engagement in the rare disease patient community.

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc, about clinical trial engagement in the rare disease patient community.

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with&nbsp;Will Maier,&nbsp;VP of Rare Disease, Drug Development Sciences at ICON plc, about clinical trial engagement in the rare disease patient community.

Episode 5:  Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.

Science

Medicine

Health & Fitness

Mental Health

Life Sciences

Welcome to Few &amp; Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.

Share Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

Sign up to save your podcasts

Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

More shows like Few & Far Between: Conversations from the Front Lines of Drug Development

This American Life

The Daily

The Readout Loud

BioCentury This Week

Biotech Hangout

The BioCentury Show